Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth

Aberrant activation of SHH pathway is a major cause of medulloblastoma (MB), the most frequent brain malignancy of the childhood. A few Hedgehog inhibitors, all antagonizing the membrane transducer Smo, have been approved or are under clinical trials for the treatment of human MB. However, the effic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Cycle
Main Authors: Di Magno, Laura, Manzi, Daniela, D’Amico, Davide, Coni, Sonia, Macone, Alberto, Infante, Paola, Di Marcotullio, Lucia, De Smaele, Enrico, Ferretti, Elisabetta, Screpanti, Isabella, Agostinelli, Enzo, Gulino, Alberto, Canettieri, Gianluca
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2014
Assuntos:
Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613849/
https://ncbi.nlm.nih.gov/pubmed/25485584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.952973
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados